Antidepressant use among paediatric patients with recent-onset inflammatory bowel disease: A nationwide case control study in Finland

Journal of Paediatrics and Child Health

Volumn 50, Issue 7, 2014, Pages 562-565

  Virta, Lauri J ^a   Kolho, Kaija Leena ^b  

^a Social Insurance Institution Research Department   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Crohn's disease; drugs; mental health; paediatric; ulcerative colitis

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; METHYLPHENIDATE; MIRTAZAPINE; PRESCRIPTION DRUG; SERTRALINE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CASE CONTROL STUDY; CHILD; CHILDHOOD DISEASE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DRUG USE; FEMALE; FINLAND; FOLLOW UP; HUMAN; INCIDENCE; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; DRUG UTILIZATION; PSYCHOLOGY; REGISTER; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; CHILD; DEPRESSION; DRUG UTILIZATION; FEMALE; FINLAND; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; REGISTRIES;

EID: 84904043115     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/jpc.12516     Document Type: Article

References (18)

1. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46-54.
2. Nieuwenhuis EE, Escher JC,. Early onset IBD: what's the difference? Dig. Liver Dis. 2008; 40: 12-15.
3. Väistö T, Aronen E, Simola P, Ashorn M, Kolho KL,. Psychosocial symptoms and competence among adolescents with inflammatory bowel disease and their peers. Inflamm. Bowel Dis. 2010; 16: 27-35.
4. Mackner LM, Greenley RN, Szighethy E, Herzer M, Deer K, Hommel KA,. Psychosocial issues in pediatric inflammatory bowel disease: report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J. Pediatr. Gastroenterol. Nutr. 2013; 56: 449-458.
5. Haapamäki J, Roine RP, Sintonen H, Kolho KL,. Health-related quality of life in paediatric patients with inflammatory bowel disease related to disease activity. J. Paedtr. Child Health 2011; 47: 832-837.
6. Gray WN, Denson LA, Baldassano RN, Hommel KA,. Disease activity, behavioral dysfunction, and health-related quality of life in adolescents with inflammatory bowel disease. Inflamm. Bowel Dis. 2011; 17: 1581-1586.
7. Szigethy E, Levy-Warren A, Whitton S, et al. Depressive symptoms and inflammatory bowel disease in children and adolescents: a cross-sectional study. J. Pediatr. Gastroenterol. Nutr. 2004; 39: 395-403.
8. Bonaz BL, Bernstein CN,. Brain-gut interactions in inflammatory bowel disease. Gastroenterology 2013; 144: 36-49.
9. Nahon S, Lahmek P, Durance C, et al. Risk factors of anxiety and depression in inflammatory bowel disease. Inflamm. Bowel Dis. 2012; 18: 2086-2091.
10. Haapamäki J, Tanskanen A, Roine RP, et al. Medication use among inflammatory bowel disease patients: excessive consumption of antidepressants and analgesics. Scand. J. Gastroenterol. 2013; 48: 42-50.
11. Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, Sørensen HT,. The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin. Pharmacol. Toxicol. 2010; 106: 86-94.
12. WHO Collaborating Centre for Drug Statistics Methodology, Norwegian Institute of Public Health. ATC/DDD Index 2012 [database]. Oslo: Norwegian Institute of Public Health, 2012. Available from: http://www.whocc.no/atc-ddd- index [accessed 22 March 2013].
13. Finnish Medicines Agency; Social Insurance Institution. Finnish Statistics on Medicines 2010. Helsinki: Edita Prima, 2011.
14. Virta L, Auvinen A, Helenius H, Huovinen P, Kolho KL,. Association of repeated exposure to antibiotics with the development of pediatric Crohn's disease-a nationwide, register-based Finnish case-control study. Am. J. Epidemiol. 2012; 175: 775-784.
15. Mikocka-Walus AA, Gordon AL, Stewart BJ, Andrews JM,. The role of antidepressants in the management of inflammatory bowel disease (IBD): a short report on a clinical case-note audit. J. Psychosom. Res. 2012; 72: 165-167.
16. Zoëga H, Furu K, Halldõrsson M, Thomsen PH, Sourander A, Martikainen JE,. Use of ADHD drugs in the Nordic countries: a population-based comparison study. Acta Psychiatr. Scand. 2011; 123: 360-367.
17. Autti-Ramo I, Sourander A, Seppanen J, Martikainen JE,. Use of antidepressants among 0-26 year olds in Finland during 1997-2007. Eur. J Psychiatr. 2011; 25: 164-172.
18. Virta LJ, Kolho KL,. Trends in early outpatient drug therapy in pediatric inflammatory bowel disease in Finland: a nationwide register-based study in 1999-2009. ISRN Gastroenterol 2012; 2012: 462642.